OA-46 Phase II Clinical Trial of Minimal Residual Disease Response-Adapted Deferral of Transplantation in Dysproteinemia (MILESTONE)

Authors:
  • SBSusan Bal
    Susan Bal
  • SGSmit Giri
    Smit Giri
  • GRGayathri Ravi
    Gayathri Ravi
  • KGKelly Godby
    Kelly Godby
  • CHCaitlin Hagedorn
    Caitlin Hagedorn
  • LJLaura Joiner
    Laura Joiner
  • FLFrances Lund
    Frances Lund
  • LCLuciano Costa
    Luciano Costa

Abstract
No abstract available